Jaguar Health, Inc.

JAGXNasdaq· Pharmaceutical Preparations

Price History

Revenue

$11.7M

▲ 19.8% YoY

Net Income

-$38.5M

▲ 6.8% YoY

EPS

$-130.69

▲ 95.1% YoY

Cash

$8.0M

▲ 23.7% YoY

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.